Linda Yu, PhD
The mission of 23andMe is to help people access, understand and benefit from the human genome. We offer reports and tools that can help people make many discoveries about themselves and their family history. In addition, our innovative research platform has the largest consented, re-contactable database for genetic research in the world. By combining phenotypic data collected through online surveys with our customers’ genotype data we are able to conduct a variety of studies to understand the effects of genetic variants on health. We have also recently established a therapeutics unit that will leverage our unique research capabilities to accelerate the discovery of novel treatments. At the heart of everything we do is our dedication to treating our customers not as research subjects, but true partners.
MEET LINDA YU
Linda Yu is a Senior Manager of Business Development and Alliances at 23andMe, a Silicon Valley-based biotech company. 23andMe provides individuals with direct access to their genetic information and offers researchers a platform to accelerate clinical development of new therapies and conduct patient-centric studies. Her main responsibility as Senior Manager is to establish and manage strategic collaborations with pharmaceutical and biotech partners. Before joining 23andMe, she was at the University of California, San Francisco, where she managed and oversaw the patenting and out-licensing of a broad range of intellectual property assets. Linda received her Ph.D. in Biological Sciences from Columbia University, where she investigated the structural and functional characteristics of metabolic enzymes implicated in obesity and type II diabetes. Prior to graduate school, Linda earned a B.S. in Biochemistry/Chemistry and a B.A. in Sociology from the University of California, San Diego (cum laude, Phi Beta Kappa).